Screener
Charles River Laboratories CRL RMS — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Service revenue | $808,287 | $840,836 | $1,606,439 | $1,638,759 |
| Product revenue | 195,791 | 191,299 | 393,469 | 377,544 |
| Total revenue | 1,004,078 | 1,032,135 | 1,999,908 | 2,016,303 |
| Costs and expenses | ||||
| Cost of services provided (excluding amortization of intangible assets) | 552,007 | 584,876 | 1,160,914 | 1,162,304 |
| Cost of products sold (excluding amortization of intangible assets) | 88,697 | 90,192 | 180,956 | 179,200 |
| Selling, general and administrative | 228,897 | 191,549 | 388,319 | 369,348 |
| Amortization of intangible assets | 14,589 | 65,384 | 29,934 | 130,648 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's RMS — total revenue?
- Charles River Laboratories (CRL) reported RMS — total revenue of $209.48M in Q2 2026.
- How has Charles River Laboratories's RMS — total revenue changed year-over-year?
- Charles River Laboratories's RMS — total revenue decreased by 1.8% year-over-year, from $213.27M to $209.48M.
- What is the long-term trend for Charles River Laboratories's RMS — total revenue?
- Over 2 years (2023 to 2025), Charles River Laboratories's RMS — total revenue has grown at a 3.3% compound annual growth rate (CAGR), from $792.34M to $846.08M.
- What does RMS — total revenue mean?
- Represents the total gross income generated by the Research Models and Services segment from its core operations. This includes the sale of research models, genetically engineered models, consulting services, and specialized diagnostic or vaccine services. It serves as the primary indicator of market demand for the segment's scientific research support offerings.
Ask your AI about Charles River Laboratories's rms — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude